Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant
CNBC Halftime Report Final Trades: Berkshire Hathaway - B Shares, Vertex Pharmaceuticals, S&P Global, CME Group
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Cantor Fitzgerald Initiates Coverage On Apellis Pharmaceuticals With Overweight Rating, Announces Price Target of $44
HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $3
Caribou Biosciences Analyst Ratings